Procter & Gamble Health Limited Fundamental Analysis (BSE: PGHL.BO)
Procter & Gamble Health Limited Fundamental Analysis (BSE: PGHL.BO)
Procter & Gamble Health Limited (BSE: PGHL.BO) shows strong financial fundamentals with a PE ratio of 24.35, profit margin of 24.91%, and ROE of 62.38%. The company generates $14.3B in annual revenue with moderate year-over-year growth of 5.80%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 75.8/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze PGHL.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakPGHL.BO struggles to generate sufficient returns from assets.
Valuation Score
ExcellentPGHL.BO trades at attractive valuation levels.
Growth Score
ExcellentPGHL.BO delivers strong and consistent growth momentum.
Financial Health Score
ModeratePGHL.BO shows balanced financial health with some risks.
Profitability Score
ExcellentPGHL.BO achieves industry-leading margins.
Key Financial Metrics
Is PGHL.BO Expensive or Cheap?
P/E Ratio
PGHL.BO trades at 24.35 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, PGHL.BO's PEG of 0.96 indicates potential undervaluation.
Price to Book
The market values Procter & Gamble Health Limited at 16.56 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 16.87 times EBITDA. This signals the market has high growth expectations.
How Well Does PGHL.BO Make Money?
Net Profit Margin
For every $100 in sales, Procter & Gamble Health Limited keeps $24.91 as profit after all expenses.
Operating Margin
Core operations generate 30.83 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $62.38 in profit for every $100 of shareholder equity.
ROA
Procter & Gamble Health Limited generates $0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Procter & Gamble Health Limited produces operating cash flow of $1.72B, showing steady but balanced cash generation.
Free Cash Flow
Procter & Gamble Health Limited generates strong free cash flow of $1.66B, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $100.14 in free cash annually.
FCF Yield
PGHL.BO converts 1.91% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
24.35
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.96
vs 25 benchmark
P/B Ratio
Price to book value ratio
16.56
vs 25 benchmark
P/S Ratio
Price to sales ratio
6.06
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.00
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.62
vs 25 benchmark
ROA
Return on assets percentage
0.00
vs 25 benchmark
ROCE
Return on capital employed
0.00
vs 25 benchmark
How PGHL.BO Stacks Against Its Sector Peers
| Metric | PGHL.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 24.35 | 30.55 | Better (Cheaper) |
| ROE | 62.38% | 608.00% | Weak |
| Net Margin | 24.91% | 15403.00% | Weak |
| Debt/Equity | 0.00 | 0.51 | Strong (Low Leverage) |
| Current Ratio | 0.00 | 5.78 | Weak Liquidity |
| ROA | 0.00% | -46.00% (disorted) | Weak |
PGHL.BO outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Procter & Gamble Health Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
37.19%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
51.52%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
-40.53%
Industry Style: Defensive, Growth, Innovation
Declining